
|Articles|June 19, 2008
Allergan's Trivaris approved to treat retinal diseases
Allergan, Trivaris, retinal diseases, vision loss, ocular
Advertisement
Trivaris (triamcinolone acetonide injectable suspension) 80 mg/mL is a new anti-inflammatory drug from
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
2
Study Identifies Patients at Risk for Severe COVID-19 Post-Vaccination
3
Investigational Oral AD109 Reduces Sleep Apnea Severity by 44%
4
Zepbound Lowers Health Care Costs in Older Adults With Obesity
5






































